Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Solana CompanyNASDAQ: HSDT
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) remains negative
Q1 FY2026 EPS (Diluted) was -$1.3, compared with -$1.42 a year earlier. Trailing-twelve-month EPS (Diluted) was -$33.93.
Context
- EPS (Diluted) grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 1 analysts of -$0.73 (+60.5%) for the fiscal year ending Dec 2026, a step up from the +57.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$1.3-130.6% QoQ
- Last fiscal yearDec 2025
- -$1.85+57.3% YoY
- LTMMar 2026
- -$33.93-654.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +8.5% | +99.5% | +91.0 pp |
| 1 year | +57.3% | +60.5% | +3.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- (1.85) USD
- Year-over-year change
- +57.3%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.85) | +57.3% |
| FY2024 | 2024-12-31 | (4.33) | +40.5% |
| FY2023 | 2023-12-31 | (7.28) | +72.1% |
| FY2022 | 2022-12-31 | (26.06) | +85.9% |
| FY2021 | 2021-12-31 | (184.51) | — |
EPS (Diluted) vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 EPS (Diluted) of -$33.93 is the lowest of the 11 companies compared; the peer median is -$1.2.
- Its year-over-year change of -654.0% is the 10th highest of 11, against a peer median of +9.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $1.17 | +48.1% | +49.0% | |
| LTM Mar 2026 | $0.99 | +111.4% | — | |
| LTM Mar 2026 | $0.38 | +162.6% | +629.0% | |
| LTM Mar 2026 | -$0.91 | +20.9% | — | |
| LTM Dec 2025 | -$1.15 | -27.8% | — | |
| LTM Mar 2026 | -$1.25 | -1.6% | — | |
| LTM Mar 2026 | -$1.41 | -24.8% | — | |
| LTM Mar 2026 | -$2.36 | -90.3% | — | |
| LTM Mar 2026 | -$4.16 | +87.4% | — | |
| LTM Mar 2026 | -$26.44 | -2085.1% | — | |
| LTM Mar 2026 | -$33.93 | -654.0% | — | |
| Peer median (excluding HSDT) | -$1.2 | +9.6% | +339.0% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 522K | 787K | 644K | 520K | 6.02M |
| Cost of Revenue | 298K | 463K | 583K | 582K | 500K |
| Gross Profit | 224K | 324K | 61K | (62K) | 5.52M |
| Gross Margin | 42.9% | 41.2% | 9.5% | -11.9% | 91.7% |
| Research & Development | 5.99M | 4.26M | 2.94M | 3.66M | 3.51M |
| Selling, General & Admin | 12.18M | 10.64M | 9.27M | 10.12M | 23.13M |
| Operating Expenses | 18.37M | 15.84M | 12.49M | 13.84M | 26.64M |
| Depreciation & Amortization | 312K | 255K | 162K | 60K | 680K |
| EBITDA | (17.82M) | (14.5M) | (12.11M) | (13.8M) | (39.58M) |
| EBITDA Margin | -3413.8% | -1842.9% | -1880.0% | -2654.4% | -657.7% |
| Operating Income | (18.14M) | (15.52M) | (12.43M) | (13.9M) | (21.12M) |
| Operating Margin | -3475.5% | -1971.5% | -1929.8% | -2673.7% | -351.0% |
| Interest Income | 0 | 0 | 257K | 0 | 0 |
| Interest Expense | 0 | 834K | 0 | 17K | 635K |
| Other Income / Expenses | 10K | 1.44M | 3.58M | 2.16M | (19.77M) |
| Income Before Tax | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Pre-Tax Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Net Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| EPS (Basic) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| EPS (Diluted) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| Weighted Avg Shares | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
| Weighted Avg Shares (Diluted) | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.